HAE HAEMONETICS CORP — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$71.28

Period return

-11.93 (-14.34%)

Volume

604.8K

2026-06-05O $70.1 H $71.66 L $69.64 C $71.28MA5 $68.12MA20 $62.12MA60 $59.65MA120 $64.93

6M · 124 barsYahoo Finance · USD2025-12-08 → 2026-06-05

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 05. 29.LowHOLD9 days ago
Citigroup: Neutral
US analyst rating / recommendation change.
2026. 05. 22.MediumBUY15 days ago
B of A Securities: Buy
US analyst rating / recommendation change.
2026. 05. 13.LowBUY25 days ago
Barrington Research: Outperform
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $81.6 · 10 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, it provides hospital products comprising TEG 6s system, smallest cartridge-based viscoelastic analyzer that provides a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, the company offers Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries;vascular closure products comprise VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen; and transfusion management solutions. It sells its products through direct sales force and independent distributors. The company was founded in 1971 and is headquartered in Boston, Massachusetts.

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 08. 06.	After market close (AMC)	$1.1	—	—	$329.7M	—	Scheduled
FY2026 Q3	2024. 12. 28.	Time TBD	—	$2.14	—	—	$1.03B	Reported
FY2026 Q2	2024. 09. 28.	Time TBD	—	$1.4	—	—	$681.68M	Reported
FY2026 Q1	2024. 06. 29.	Time TBD	—	$0.74	—	—	$336.17M	Reported

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 05. 29.	Citigroup	—	Maintain	Neutral → Neutral	—	Citigroup: Neutral
2026. 05. 22.	B of A Securities	—	Upgrade	Neutral → Buy	—	B of A Securities: Neutral → Buy
2026. 05. 13.	Barrington Research	—	Maintain	Outperform → Outperform	—	Barrington Research: Outperform
2026. 05. 09.	JP Morgan	—	Maintain	Neutral → Neutral	—	JP Morgan: Neutral
2026. 04. 14.	Mizuho	—	Maintain	Outperform → Outperform	—	Mizuho: Outperform
2026. 03. 12.	Citigroup	—	Maintain	Neutral → Neutral	—	Citigroup: Neutral

HAEMONETICS CORP

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats